N-Allyl-and N-[(cyclopropyl)methyl]-3,4-dimethoxy-5-methylmorphinan-6-one (9 and 10, resp.) were synthesized from 5-methyldihydrothebainone (1). This essential intermediate was prepared from thebaine via 5-methylthebaine (5) employing a novel route. The pharmacological studies showed 9 and 10 to be potent opioid agonists. Compound 10 was found to have preference for kappa rather than mu opioid receptors.Introduction. -The opioid agonistic properties of N-methylmorphinan-6-ones are very much dependent on the substitution pattern at the aromatic ring [l]. Besides the 'natural' substitution pattern 3-hydroxy-4,5-epoxy, the 4-monomethoxy and the 3,4-dimethoxy substitution was found to be most effective. Among the compounds with high antinociceptive potency was 3,4-dimethoxy-5,17-dimethylrnorphinan-6-one (6) [2], which prompted us to replace its N-CH, group by substituents known to introduce in most cases opioid antagonistic effects in morphinans. We chose the N-ally1 and the N-(cyclopropy1)-methyl group which are present in the opioid antagonists naloxone and naltrexone, respectively.